Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Biochem J ; 270(2): 531-7, 1990 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-2400399

RESUMO

Although they share the active-site catalytic triad of less-specific enzymes such as trypsin and chymotrypsin, the serine proteinases of the complement and coagulation cascades each cleave a highly restricted set of substrates. Peptides with sequences similar to that at which C3 is cleaved by the alternative-pathway complement proteinase CVFBb were synthesized by solid-phase methodology and examined for their effects on the activity of this enzyme as measured by three different types of assays. It was found that a peptide methylated at the scissile bond was a far more effective inhibitor of the cleavage of the protein substrate C5 and of the lysis of guinea-pig erythrocytes by the alternative pathway than was the equivalent unmethylated peptide. Whereas the unmethylated peptide inhibited cleavage of the peptide substrate, the methylated peptide actually stimulated cleavage in this assay. This stimulation was found to be due to a 2.8-fold increase in kcat; the dissociation constant for the substrate was not altered significantly. One model consistent with this behaviour is that the binding of the activator peptide in the extended substrate-recognition region stabilizes a catalytically more active conformation of the active site. A small peptide substrate may have access to such an activated active site, whereas the larger substrate, C5, may be excluded from the site. These results demonstrate that the observed effect of a given compound on activity of an enzyme with an extended substrate-recognition region may depend upon the substrate.


Assuntos
Fator B do Complemento/antagonistas & inibidores , Precursores Enzimáticos/antagonistas & inibidores , Peptídeos/farmacologia , Sequência de Aminoácidos , Animais , Sítios de Ligação , Complemento C5/metabolismo , Fator B do Complemento/metabolismo , Venenos Elapídicos/farmacologia , Cobaias , Hemólise , Cinética , Metilação , Dados de Sequência Molecular , Peptídeos/síntese química , Conformação Proteica , Espectrometria de Fluorescência , Relação Estrutura-Atividade
2.
J Biol Chem ; 263(25): 12690-7, 1988 Sep 05.
Artigo em Inglês | MEDLINE | ID: mdl-3045125

RESUMO

The generation of two cleavage products of human C3, termed C3o and C3p, by incubation with a C3-cleaving protease isolated from cobra venom (Naja naja siamensis) is described. The venom protease removes the C3p fragment (Mr approximately 33,000) from the C3dg region of the C3 alpha-chain. The major cleavage fragment C3o (Mr approximately 140,000) contains the unaltered beta-chain of C3 and two alpha-chain-derived polypeptides of Mr approximately 29,000 and Mr approximately 38,000, respectively. Amino-terminal amino acids sequence analysis of C3p and the three chains of C3o allowed the identification of the exact location of the two alpha-chain-derived fragments of C3o and the three cleavage sites of the venom protease. The chain structure of C3o resembles those of C3c and cobra venom factor. In contrast to C3c but like cobra venom factor (and C3b), C3o was found to support the activation of the serine protease Factor B by cleavage in the presence of Factor D and Mg2+ into Bb and Ba, generating an enzymatically active complex that is able to cleave a fluorogenic peptide substrate for C3 convertases. Since the only stretch of amino acid residues of C3o not present in C3c is the carboxyl terminus of the Mr approximately 29,000 chain of C3o, it is suggested that this region is important for the interaction with Factor B and convertase formation.


Assuntos
Complemento C3/metabolismo , Venenos Elapídicos/metabolismo , Fragmentos de Peptídeos/metabolismo , Sequência de Aminoácidos , Cromatografia em Gel , Ativação do Complemento , Fator B do Complemento/metabolismo , Fator D do Complemento/farmacologia , Venenos Elapídicos/análise , Eletroforese em Gel de Poliacrilamida , Humanos , Imunoeletroforese , Dados de Sequência Molecular , Peso Molecular , Fragmentos de Peptídeos/isolamento & purificação , Fragmentos de Peptídeos/farmacologia , Peptídeo Hidrolases/metabolismo
3.
J Biol Chem ; 261(24): 11038-44, 1986 Aug 25.
Artigo em Inglês | MEDLINE | ID: mdl-3090042

RESUMO

An alternative pathway C3 convertase is formed by the equilibrium association of Factor B with cobra venom factor (CVF) followed by the activation step catalyzed by Factor D. However, the association of Factor B with CVF has only occasionally been demonstrated and has not been quantitatively analyzed. Here we show that in the absence of metals the two proteins have significant affinity for each other and reversibly associate in a one-to-one stoichiometry with a dissociation constant of 11.6 microM. Upon the addition of metal ions, the complex is stabilized only 2- to 30-fold in the order Ni2+(Kd = 6.6 microM) less than Mg2+(Kd = 1.1 microM) less than Mn2+(Kd = 0.4 microM). These results suggest that metal ions may be less important in stabilizing the CVF.B complex and more important in promoting the subsequent equilibrium association of CVF.B with Factor D. The stability of the CVF.B complex is variously dependent on temperature in the range studied (14-21 degrees C) depending on the metal ion that is present. The complex formation was demonstrated in the analytical ultracentrifuge at sedimentation equilibrium employing a combination of single- and multiple-independent variable nonlinear least squares analytical techniques. Two different numerical approaches gave very similar results.


Assuntos
Fator B do Complemento/metabolismo , Venenos Elapídicos/metabolismo , Precursores Enzimáticos/metabolismo , Ácido Edético/farmacologia , Humanos , Magnésio/farmacologia , Manganês/farmacologia , Matemática , Níquel/farmacologia , Temperatura , Termodinâmica , Ultracentrifugação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA